Developer docs
API playgroundTry for free, no card

Search company profiles

Eggnovo

Full company profile

uuid000dvbe

Namestring
Eggnovo
Legal namestring
EGGNOVO S.L.
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Eggnovo S.L. is a Spanish biotechnology company founded in 2012 in Villatuerta, Navarra, that manufactures branded functional ingredients derived from eggshell membrane and eggshell through a patented circular-economy process. The company extracts and preserves a matrix of naturally occurring bioactive compounds — including collagen types I, V and X, hyaluronic acid, elastin, chondroitin sulphate, glucosamine, and over 400 biomolecules — and converts eggshell calcium into a multimineral matrix and an upcycled industrial calcium carbonate. The proprietary portfolio comprises seven trademarked ingredients: Ovomet (joint health and mobility), Ovoderm (skin, hair, nail beauty-from-within), Ovocet (bone health), Ovopet (pet health), RejuveColl Triple Active and Mineralsens (cosmetics), and Circular Carb (industrial fillers for plastics, rubber, paints and ceramics).

Eggnovo operates a sales-led B2B ingredients model, supplying formulators and manufacturers in the nutraceutical, food & beverage, cosmetic, pet nutrition, and industrial sectors across more than 50 countries. Manufacturing is centralized at a single facility in Villatuerta, with commercial offices in Spain (Tajonar) and France supporting international customer engagement. The company offers galenic-format variants (capsules, softgels, vials, powders, tablets, gummies, liquid shots) for compatibility with diverse supplement and food matrices, and substantiates efficacy with over 20 in vivo, in vitro, and clinical studies. FSSC 22000 and Halal certifications position the platform for global food, supplement, and Middle East/Asia distribution.

Revenue mechanics are based on direct B2B ingredient sales to enterprise manufacturers at quote-based, undisclosed pricing. The company reported revenue above €10 million in 2025, with 30%+ annual growth between 2020 and 2025. In March 2026, Aleos Capital acquired a majority stake through its inaugural fund Aleos Fund I — with participation from an international sector-experienced investor — to fund expansion into Asia and the United States and to develop new applications in cosmetics, food & beverages, and eco-industrial solutions. The company employs 40 people as of 2025.

Short descriptiontext

Eggnovo S.L. is a Spanish biotechnology company that manufactures patented, branded functional ingredients from eggshell membrane and shell via a circular-economy process, supplying nutraceutical, cosmetic, food & beverage, pet nutrition, and industrial manufacturers across 50+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersVillatuerta, Spain
HQ citystring
Villatuerta
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
nutraceutical ingredients, eggshell membrane, functional ingredients, upcycled ingredients, circular economy manufacturing
Industry3 codes
1Egg ingredient manufacturing (albumen, yolk solids, egg protein isolates/hydrolysates)
CodeAFANAHAGPrimaryYes
2Eggs & Egg Products (Shell, Liquid, Value-Added)
CodeCRADACAJPrimaryNo
3Value-Added Egg Products (Hard-Boiled, Omelets, Egg Mixes) Wholesale
CodeAFAIAEAHPrimaryNo
NAICS code1 code
  • Food Manufacturing311
SIC code2 codes
  • Food And Kindred Products2000
  • Miscellaneous Food Preparations & Kindred Products2090
Product category
Nutraceutical ingredients
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1B2B Ingredient Sales
TypeOne Time License
Description

Eggnovo generates revenue by selling its branded functional ingredients (OVOMET, OVODERM, OVOCET, OVOPET, RejuveColl, Circular Carb) to nutraceutical, cosmetic, food & beverage, pet nutrition, and industrial manufacturers. The company operates on a B2B model supplying raw materials for dietary supplements, functional foods, cosmetics, and industrial applications.

eggnovo.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Technology or R&D, Personnel, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Eggnovo manufactures and sells branded functional ingredients extracted from eggshell membrane and shells through a patented circular economy process. Its portfolio — including OVOMET (joint health), OVODERM (skin/hair/nail), OVOCET (bone health), OVOPET (pet health), RejuveColl and Mineralsens (cosmetics), and Circular Carb (industrial) — is supplied B2B to nutraceutical, food & beverage, cosmetic, pet nutrition, and industrial manufacturers in over 50 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 300mg daily dose of OVOMET demonstrates significant reduction in joint pain and stiffness within 5 days
+2 more records
Product overview1 text field

Eggnovo is a biotechnology company that develops and manufactures natural functional ingredients extracted from eggshell membranes and shells through a circular economy model. Their portfolio includes branded ingredients for the nutraceutical, cosmetic, food & beverage, pet nutrition, and industrial sectors. Core products include Ovomet® (vegetarian collagen for joint health and mobility), Ovoderm® (beauty-from-within collagen for skin, hair, and nails), Ovocet® (calcium multimineral matrix for bone health), and Ovopet® (eggshell membrane for pet health). Cosmetic offerings comprise RejuveColl™ – Triple Active (skin rejuvenation ingredient) and Mineralsens™ (calcium carbonate for cosmetics). Industrial applications are served through Circular Carb™ (bio-based calcium carbonate filler for plastics, rubber, paints, and ceramics). All ingredients are science-backed with over 20 in vivo, in vitro, and clinical studies and are produced through a patented, 100% renewable, zero-waste process.

Product and service7 records
1OVOMET®
CategoryNutraceutical ingredient
Description

Natural vegetarian collagen type I, V & X sourced from eggshell membrane, designed to support joint health and mobility with a 300mg daily dose. Contains hyaluronic acid, elastin, chondroitin sulphate, and glucosamine. Sold B2B to nutraceutical and supplement manufacturers.

2OVODERM®
CategoryNutraceutical ingredient
Description

Natural vegetarian collagen type I, V & X from eggshell membrane formulated for hair, nails, and skin health with a 300mg daily dose. Contains hyaluronic acid and elastin for skin elasticity and hydration. Sold B2B to nutraceutical and supplement manufacturers.

3OVOCET®
CategoryNutraceutical ingredient
Description

Natural and upcycled calcium multimineral matrix from eggshell containing calcium carbonate, strontium, magnesium, phosphorus, zinc, and soluble transport proteins. Highly bioavailable source for bone, muscle, and teeth health. Sold B2B to nutraceutical and supplement manufacturers.

4OVOPET®
CategoryPet nutrition ingredient
Description

Natural eggshell membrane ingredient for pet health containing collagen, hyaluronic acid, elastin, chondroitin sulphate, and glucosamine among 400 biomolecules. Supports joint, skin, and gut health in dogs, cats, and horses. Sold B2B to pet nutrition and animal health manufacturers in formats including supplements, treats, powders, tablets, capsules, dry & wet food, pellets, and soft chews.

5RejuveColl™ – Triple Active
CategoryCosmetic ingredient
Description

Natural cosmetic ingredient derived from eggshell membrane containing collagen and elastin peptides, hyaluronic acid, and over 400 biomolecules. Provides holistic skin rejuvenation, barrier restoration, and anti-aging benefits at 1-5% concentration. Sold B2B to cosmetics and personal care brands for use in toners, masks, hair lotions, serums, and creams.

6Mineralsens™
CategoryCosmetic ingredient
Description

High-purity calcium carbonate ingredient for cosmetic formulations derived from eggshells. Sold B2B to cosmetics and personal care brands.

7Circular Carb™
CategoryIndustrial ingredient
Description

Sustainable bio-based calcium carbonate filler from upcycled eggshells for industrial applications including plastics, rubber, paints, coatings, and ceramics. Produced through patented circular economy processes with low carbon footprint, compatible with different plastic matrixes and improving mechanical, thermal, and processing properties. Sold B2B to industrial materials manufacturers.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeOthers
Description

Eggnovo aligns with the UN 2030 Sustainable Development Goals (SDGs), contributing to strategic areas within the SDG framework including responsible consumption and production, good health and well-being, and other sustainability objectives through its circular economy operations and upcycled ingredient business model.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based supplier of water-soluble eggshell membrane ingredients for joint, skin, and animal health applications. Direct competitor in the eggshell membrane ingredient category with overlapping product positioning (joint health, beauty) and a similar B2B ingredient-supply model.

TypeDirect peer
Description

Markets NEM® (Natural Eggshell Membrane), a branded eggshell membrane ingredient for joint and connective tissue health sold to supplement manufacturers. Closest US-based direct peer with shared ingredient category, clinical-study-backed claims, and B2B nutraceutical customers.

TypeDirect peer
Description

Spanish-based life-science company producing bioactive ingredients for joint health, mobility, and animal nutrition from natural sources. Iberian peer with overlapping joint-health ingredient portfolio and B2B nutraceutical/pet-nutrition customer base.

TypeBroad incumbent
Description

Global leader in collagen peptides and gelatin for nutraceutical, food, and pharmaceutical applications. Serves the same supplement and functional-food formulators that Eggnovo targets, with much broader portfolio and deeper distribution.

TypeBroad incumbent
Description

World-leading gelatin and collagen peptide manufacturer owned by Darling Ingredients. Competes head-to-head with Eggnovo in collagen-positioned ingredients for nutraceutical and food applications, with far greater scale and global reach.

TypeBroad incumbent
Description

Part of Tessenderlo Group, producing gelatin, collagen peptides, and related functional ingredients for food, nutraceutical, and pet nutrition. Overlaps with Eggnovo's collagen, pet nutrition, and food & beverage verticals.

7Specnova
TypeEmerging player
Description

Ingredient supplier specializing in egg-based and shell-membrane ingredients for joint and connective tissue health. Niche competitor with similar upstream feedstock and product positioning, focused on the supplement channel.

TypeBroad incumbent
Description

Leading consumer collagen and wellness supplement brand. Although a finished-product brand rather than an ingredient supplier, it defines the market Eggnovo's nutraceutical customers serve and shapes competitive positioning across beauty-from-within and joint health categories.

TypeBroad incumbent
Description

Air Liquide subsidiary supplying specialty ingredients for cosmetics, nutrition, and pharma. Overlaps with Eggnovo's RejuveColl and Mineralsens cosmetic ingredient offerings and serves the same beauty and personal care formulators.

TypeBroad incumbent
Description

Belgian specialty group whose PB Leiner division competes in collagen and gelatin ingredients for food, nutrition, and pet applications. Comparable as a diversified specialty ingredient platform with broader scale than Eggnovo.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Eggnovo

Nutraceutical ingredientseggnovo.com

Eggnovo S.L. is a Spanish biotechnology company that manufactures patented, branded functional ingredients from eggshell membrane and shell via a circular-economy process, supplying nutraceutical, cosmetic, food & beverage, pet nutrition, and industrial manufacturers across 50+ countries.

What Eggnovo does

Eggnovo S.L. is a Spanish biotechnology company founded in 2012 in Villatuerta, Navarra, that manufactures branded functional ingredients derived from eggshell membrane and eggshell through a patented circular-economy process. The company extracts and preserves a matrix of naturally occurring bioactive compounds — including collagen types I, V and X, hyaluronic acid, elastin, chondroitin sulphate, glucosamine, and over 400 biomolecules — and converts eggshell calcium into a multimineral matrix and an upcycled industrial calcium carbonate. The proprietary portfolio comprises seven trademarked ingredients: Ovomet (joint health and mobility), Ovoderm (skin, hair, nail beauty-from-within), Ovocet (bone health), Ovopet (pet health), RejuveColl Triple Active and Mineralsens (cosmetics), and Circular Carb (industrial fillers for plastics, rubber, paints and ceramics).

Eggnovo operates a sales-led B2B ingredients model, supplying formulators and manufacturers in the nutraceutical, food & beverage, cosmetic, pet nutrition, and industrial sectors across more than 50 countries. Manufacturing is centralized at a single facility in Villatuerta, with commercial offices in Spain (Tajonar) and France supporting international customer engagement. The company offers galenic-format variants (capsules, softgels, vials, powders, tablets, gummies, liquid shots) for compatibility with diverse supplement and food matrices, and substantiates efficacy with over 20 in vivo, in vitro, and clinical studies. FSSC 22000 and Halal certifications position the platform for global food, supplement, and Middle East/Asia distribution.

Revenue mechanics are based on direct B2B ingredient sales to enterprise manufacturers at quote-based, undisclosed pricing. The company reported revenue above €10 million in 2025, with 30%+ annual growth between 2020 and 2025. In March 2026, Aleos Capital acquired a majority stake through its inaugural fund Aleos Fund I — with participation from an international sector-experienced investor — to fund expansion into Asia and the United States and to develop new applications in cosmetics, food & beverages, and eco-industrial solutions. The company employs 40 people as of 2025.

Eggnovo firmographics

Firmographics
Name
Eggnovo
Legal name
EGGNOVO S.L.
Website
https://eggnovo.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
Eggnovo S.L. is a Spanish biotechnology company that manufactures patented, branded functional ingredients from eggshell membrane and shell via a circular-economy process, supplying nutraceutical, cosmetic, food & beverage, pet nutrition, and industrial manufacturers across 50+ countries.
Ownership category
akta.pro rank

Eggnovo industry classification

Industry
Product category
Nutraceutical ingredients
NAICS
Food Manufacturing (311)
SIC
Food And Kindred Products (2000), Miscellaneous Food Preparations & Kindred Products (2090)
akta.pro primary industry
Egg ingredient manufacturing (albumen, yolk solids, egg protein isolates/hydrolysates) (AFANAHAG)
akta.pro secondary industries
Eggs & Egg Products (Shell, Liquid, Value-Added) (CRADACAJ), Value-Added Egg Products (Hard-Boiled, Omelets, Egg Mixes) Wholesale (AFAIAEAH)

Keywords

  • Nutraceutical ingredients
  • Eggshell membrane
  • Functional ingredients
  • Upcycled ingredients
  • Circular economy manufacturing

Where Eggnovo is headquartered

Location

Headquarters

HQ city
Villatuerta
HQ country
Spain
HQ region
Europe

Offices3 records

Markets served

Eggnovo business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Technology or R&D, Personnel, Supply Chain, Marketing or Sales

Revenue model

  1. B2B Ingredient Sales: Eggnovo generates revenue by selling its branded functional ingredients (OVOMET, OVODERM, OVOCET, OVOPET, RejuveColl, Circular Carb) to nutraceutical, cosmetic, food & beverage, pet nutrition, and industrial manufacturers. The company operates on a B2B model supplying raw materials for dietary supplements, functional foods, cosmetics, and industrial applications.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Eggnovo product offering

Product offering

Core offering

Eggnovo manufactures and sells branded functional ingredients extracted from eggshell membrane and shells through a patented circular economy process. Its portfolio — including OVOMET (joint health), OVODERM (skin/hair/nail), OVOCET (bone health), OVOPET (pet health), RejuveColl and Mineralsens (cosmetics), and Circular Carb (industrial) — is supplied B2B to nutraceutical, food & beverage, cosmetic, pet nutrition, and industrial manufacturers in over 50 countries.

Product overview

Eggnovo is a biotechnology company that develops and manufactures natural functional ingredients extracted from eggshell membranes and shells through a circular economy model. Their portfolio includes branded ingredients for the nutraceutical, cosmetic, food & beverage, pet nutrition, and industrial sectors. Core products include Ovomet® (vegetarian collagen for joint health and mobility), Ovoderm® (beauty-from-within collagen for skin, hair, and nails), Ovocet® (calcium multimineral matrix for bone health), and Ovopet® (eggshell membrane for pet health). Cosmetic offerings comprise RejuveColl™ – Triple Active (skin rejuvenation ingredient) and Mineralsens™ (calcium carbonate for cosmetics). Industrial applications are served through Circular Carb™ (bio-based calcium carbonate filler for plastics, rubber, paints, and ceramics). All ingredients are science-backed with over 20 in vivo, in vitro, and clinical studies and are produced through a patented, 100% renewable, zero-waste process.

Differentiator

Problem solved

Functional benefit

Products and services

  • OVOMET® Natural vegetarian collagen type I, V & X sourced from eggshell membrane, designed to support joint health and mobility with a 300mg daily dose. Contains hyaluronic acid, elastin, chondroitin sulphate, and glucosamine. Sold B2B to nutraceutical and supplement manufacturers.
  • OVODERM® Natural vegetarian collagen type I, V & X from eggshell membrane formulated for hair, nails, and skin health with a 300mg daily dose. Contains hyaluronic acid and elastin for skin elasticity and hydration. Sold B2B to nutraceutical and supplement manufacturers.
  • OVOCET® Natural and upcycled calcium multimineral matrix from eggshell containing calcium carbonate, strontium, magnesium, phosphorus, zinc, and soluble transport proteins. Highly bioavailable source for bone, muscle, and teeth health. Sold B2B to nutraceutical and supplement manufacturers.
  • OVOPET® Natural eggshell membrane ingredient for pet health containing collagen, hyaluronic acid, elastin, chondroitin sulphate, and glucosamine among 400 biomolecules. Supports joint, skin, and gut health in dogs, cats, and horses. Sold B2B to pet nutrition and animal health manufacturers in formats including supplements, treats, powders, tablets, capsules, dry & wet food, pellets, and soft chews.
  • RejuveColl™ – Triple Active Natural cosmetic ingredient derived from eggshell membrane containing collagen and elastin peptides, hyaluronic acid, and over 400 biomolecules. Provides holistic skin rejuvenation, barrier restoration, and anti-aging benefits at 1-5% concentration. Sold B2B to cosmetics and personal care brands for use in toners, masks, hair lotions, serums, and creams.
  • Mineralsens™ High-purity calcium carbonate ingredient for cosmetic formulations derived from eggshells. Sold B2B to cosmetics and personal care brands.
  • Circular Carb™ Sustainable bio-based calcium carbonate filler from upcycled eggshells for industrial applications including plastics, rubber, paints, coatings, and ceramics. Produced through patented circular economy processes with low carbon footprint, compatible with different plastic matrixes and improving mechanical, thermal, and processing properties. Sold B2B to industrial materials manufacturers.

Quantifiable outcome

  • 300mg daily dose of OVOMET demonstrates significant reduction in joint pain and stiffness within 5 days
  • +2 more outcomes

Companies that use Eggnovo

Customer profile

Named customers1 record

Segments5 records

Ideal customer profiles5 records

Eggnovo technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Eggnovo partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • United Nations (SDG Alignment)minorOthersEggnovo aligns with the UN 2030 Sustainable Development Goals (SDGs), contributing to strategic areas within the SDG framework including responsible consumption and production, good health and well-being, and other sustainability objectives through its circular economy operations and upcycled ingredient business model.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Eggnovo competitors and assessment

Company assessment

Direct peers

  • Biova: US-based supplier of water-soluble eggshell membrane ingredients for joint, skin, and animal health applications. Direct competitor in the eggshell membrane ingredient category with overlapping product positioning (joint health, beauty) and a similar B2B ingredient-supply model.
  • Stratum Nutrition (ESM Technologies): Markets NEM® (Natural Eggshell Membrane), a branded eggshell membrane ingredient for joint and connective tissue health sold to supplement manufacturers. Closest US-based direct peer with shared ingredient category, clinical-study-backed claims, and B2B nutraceutical customers.
  • Bioiberica: Spanish-based life-science company producing bioactive ingredients for joint health, mobility, and animal nutrition from natural sources. Iberian peer with overlapping joint-health ingredient portfolio and B2B nutraceutical/pet-nutrition customer base.

Broad incumbents

  • GELITA: Global leader in collagen peptides and gelatin for nutraceutical, food, and pharmaceutical applications. Serves the same supplement and functional-food formulators that Eggnovo targets, with much broader portfolio and deeper distribution.
  • Rousselot: World-leading gelatin and collagen peptide manufacturer owned by Darling Ingredients. Competes head-to-head with Eggnovo in collagen-positioned ingredients for nutraceutical and food applications, with far greater scale and global reach.
  • PB Leiner: Part of Tessenderlo Group, producing gelatin, collagen peptides, and related functional ingredients for food, nutraceutical, and pet nutrition. Overlaps with Eggnovo's collagen, pet nutrition, and food & beverage verticals.
  • Vital Proteins: Leading consumer collagen and wellness supplement brand. Although a finished-product brand rather than an ingredient supplier, it defines the market Eggnovo's nutraceutical customers serve and shapes competitive positioning across beauty-from-within and joint health categories.
  • Seppic: Air Liquide subsidiary supplying specialty ingredients for cosmetics, nutrition, and pharma. Overlaps with Eggnovo's RejuveColl and Mineralsens cosmetic ingredient offerings and serves the same beauty and personal care formulators.
  • Tessenderlo Group: Belgian specialty group whose PB Leiner division competes in collagen and gelatin ingredients for food, nutrition, and pet applications. Comparable as a diversified specialty ingredient platform with broader scale than Eggnovo.

Emerging players

  • Specnova: Ingredient supplier specializing in egg-based and shell-membrane ingredients for joint and connective tissue health. Niche competitor with similar upstream feedstock and product positioning, focused on the supplement channel.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Eggnovo social profiles

Digital presence

Eggnovo compliance and trust

Trust signal

Compliance2 records

Eggnovo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Eggnovo leadership team

Management profile

Number of profiles

Profiles1 record

Eggnovo funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Eggnovo M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eggnovo

What does Eggnovo do?

Eggnovo manufactures and sells branded functional ingredients extracted from eggshell membrane and shells through a patented circular economy process. Its portfolio — including OVOMET (joint health), OVODERM (skin/hair/nail), OVOCET (bone health), OVOPET (pet health), RejuveColl and Mineralsens (cosmetics), and Circular Carb (industrial) — is supplied B2B to nutraceutical, food & beverage, cosmetic, pet nutrition, and industrial manufacturers in over 50 countries.

Is Eggnovo a public or private company?

Eggnovo is a private company. It is classified as private equity controlled and is currently operating.

When was Eggnovo founded?

Eggnovo was founded in 2012. It employs 11 to 50 people.

Where is Eggnovo based?

Eggnovo is headquartered in Villatuerta, Spain, in the Europe region.

How does Eggnovo make money?

One revenue line is on record: B2B Ingredient Sales.

Who are Eggnovo's main competitors?

Direct peers on record are Biova, Stratum Nutrition (ESM Technologies) and Bioiberica. Broad incumbents are GELITA, Rousselot, PB Leiner, Vital Proteins, Seppic and Tessenderlo Group. Specnova is listed as an emerging player.

Does Eggnovo have an API?

No public API is recorded for Eggnovo.

What industry is Eggnovo in?

Eggnovo's product category is Nutraceutical ingredients. Its primary akta.pro industry code is AFANAHAG, Egg ingredient manufacturing (albumen, yolk solids, egg protein isolates/hydrolysates), with a secondary code of CRADACAJ, Eggs & Egg Products (Shell, Liquid, Value-Added). Its NAICS code is 311 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
CuatrecasasAleos Capital acquires majority stake in EggnovoAleos Capital, a Spanish private equity firm, has acquired a majority stake in Eggnovo, a company that produces natural ingredients extracted from eggshell membranes for the food, health, and cosmetics industries. This transaction marks the first investment made by Aleos Capital through its fund and will enable Eggnovo to accelerate its growth and strengthen its international expansion. Cuatrecasas acted as legal advisor to Aleos Capital on the transaction.Empresas de Capital Riesgo en EspaCuatrecasas advises Aleos Capital on its first investment, the acquisition of a majority stake in EggnovoCuatrecasas, a law firm, advised Aleos Capital, a Spanish private equity firm, on acquiring a majority stake in Eggnovo, marking Aleos Capital's first investment through its fund. Eggnovo is a high-growth company that produces natural ingredients extracted from egg shell membrane for the food, health, and cosmetic sectors, combining compounds such as collagen, hyaluronic acid, and elastin. The transaction is expected to support Eggnovo's growth and reinforce its international expansion in the natural ingredients market for nutraceutical, cosmetic, veterinary, and food applications.WebcapitalriesgoAleos Capital adquiere Eggnovo y estrena su primer fondoAleos Capital, a private equity firm, has completed its first fund launch by acquiring a majority stake in Eggnovo, a Spanish biotechnology company that develops natural ingredients derived from eggshell membrane for nutraceutical, cosmetic, veterinary, and food applications. Eggnovo is based in Villatuerta, Navarra, and generates over €10 million in revenue with more than 30% annual growth between 2020 and 2025, employing 40 people. The capital raised will be used to fund Eggnovo's growth strategy, strengthen its international expansion, and consolidate its market positioning.Empresas de Capital Riesgo en EspaAleos Capital partners with Eggnovo, the European leader in functional egg membrane ingredients, to consolidate its growthAleos Capital, through its fund Aleos Fund I, has acquired a majority stake in Eggnovo, the European leader in functional ingredients derived from eggshell membrane, with an international sector-experienced investor also participating in the deal. Eggnovo, founded in 2012 and headquartered in Villatuerta, Spain, has experienced over 30% annual revenue growth between 2020 and 2025, surpassing €10 million, and operates a circular economy model processing millions of eggshells daily into high-value ingredients for nutraceutical, cosmetic, veterinary, and food applications. The partnership aims to consolidate Eggnovo's international expansion, particularly in Asia and the United States, while developing new natural applications in cosmetics, food and beverages, and eco-industrial solutions.